It has been recently observed that SIRT4 inhibition increases mitochondrial function and fatty acid oxidation in liver and muscle cells, suggesting therapeutic benefits for metabolic diseases such as type 2 diabetes [32]. This evidence concerns the gene SIRT4 and type 2 diabetes mellitus.